Sort
15,842 grants matching “pancreatic cancer”
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
$1,133,624Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$1,133,624Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Texas Medical Center Digestive Diseases Center
$1,133,467Hashem B El-Serag · Baylor College Of Medicine · P30 · FY2019 · DK
Preclinical drug development in pancreatic cancer
$1,131,974Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Multi-Center Study of Pancreatic Cancer Etiology
$1,131,891John D Potter · Kaiser Foundation Health Plan Of Washington · R01 · FY2007 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,131,504Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2020 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,131,312Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2023 · CA
Xenobiotic-Metabolizing Enzymes
$1,130,184Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,129,408Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,129,373Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$1,128,458Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Cancer Risk in Human Populations
$1,126,839Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$1,125,781Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$1,125,781Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
PNNL Proteome Characterization Center
$1,123,778Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2016 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,123,750Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
$1,123,263Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,122,823Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2023 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,122,822Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2022 · CA
Modulation of Therapeutic Response
$1,121,091James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
SPORE in Pancreatic Cancer
$1,119,167James L Abbruzzese · University Of Tx Md Anderson Can Ctr · P20 · FY2006 · CA
Molecular Pathogenesis of Digestive Diseases
$1,119,132Harry Bernard Greenberg · Stanford University · P30 · FY2007 · DK
Molecular Pathogenesis of Digestive Diseases
$1,119,132Harry Bernard Greenberg · Stanford University · P30 · FY2009 · DK
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,117,299Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Commercializing CivaSheet for Pancreatic Cancer Patients
$1,117,042Kristy Perez · Civatech Oncology, Inc. · R44 · FY2024 · CA